Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Frank MO, Kaufman J, Tian S, Suárez-Fariñas M, Parveen S, Blachère NE, Morris MJ, Slovin S, Scher HI, Albert ML, Darnell RB.

PLoS One. 2010 Sep 1;5(9). pii: e12367. doi: 10.1371/journal.pone.0012367.

2.

Prostate cancer vaccines: current status and future potential.

Doehn C, Böhmer T, Kausch I, Sommerauer M, Jocham D.

BioDrugs. 2008;22(2):71-84. Review.

PMID:
18345705
3.

Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.

[No authors listed]

Drugs R D. 2006;7(3):197-201. Review.

PMID:
16752945
4.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
5.

[Vaccine therapy of prostate cancer].

Doehn C, Böhmer T, Sommerauer M, Kausch I, Jocham D.

Aktuelle Urol. 2005 Sep;36(5):407-16. Review. German.

PMID:
16163603
6.

CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

Lubaroff DM, Karan D.

Adv Drug Deliv Rev. 2009 Mar 28;61(3):268-74. doi: 10.1016/j.addr.2008.12.005. Epub 2009 Jan 7. Review.

PMID:
19166887
7.

PSA-based vaccines for the treatment of prostate cancer.

Madan RA, Gulley JL, Arlen PM.

Expert Rev Vaccines. 2006 Apr;5(2):199-209. Review.

PMID:
16608420
8.

Advances in prostate cancer immunotherapies.

Basler M, Groettrup M.

Drugs Aging. 2007;24(3):197-221. Review.

PMID:
17362049
9.

Current vaccination strategies for prostate cancer.

Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, Vogelzang NJ, Wirth M, Van Poppel H, Osanto S.

Eur Urol. 2012 Feb;61(2):290-306. doi: 10.1016/j.eururo.2011.09.020. Epub 2011 Oct 3. Review.

PMID:
22001436
10.

[State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus].

Eymard JC, Gervais A, Jarcau R, Bernard J.

Bull Cancer. 2007 Jul;94(7 Suppl):F69-76. Review. French.

PMID:
17845996
11.

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer.

Matera L.

Cancer Treat Rev. 2010 Apr;36(2):131-41. doi: 10.1016/j.ctrv.2009.11.002. Epub 2009 Dec 1. Review.

PMID:
19954892
12.

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.

PMID:
18061335
13.

[Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer: a systematic review and meta-analysis].

Wu K, Meng JS, Baihetiya A, Wang YJ.

Zhonghua Nan Ke Xue. 2013 Jun;19(6):545-50. Review. Chinese.

PMID:
23862236
14.

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.

Draube A, Klein-González N, Mattheus S, Brillant C, Hellmich M, Engert A, von Bergwelt-Baildon M.

PLoS One. 2011 Apr 20;6(4):e18801. doi: 10.1371/journal.pone.0018801. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk